Literature DB >> 33408180

Tetramerization of Phosphoprotein is Essential for Respiratory Syncytial Virus Budding while its N Terminal Region Mediates Direct Interactions with the Matrix Protein.

Monika Bajorek1, Marie Galloux2, Charles-Adrien Richard2, Or Szekely3, Rina Rosenzweig3, Christina Sizun4, Jean-Francois Eleouet2.   

Abstract

It was shown previously that the Matrix (M), Phosphoprotein (P), and the Fusion (F) proteins of Respiratory syncytial virus (RSV) are sufficient to produce virus-like particles (VLPs) that resemble the RSV infection-induced virions. However, the exact mechanism and interactions among the three proteins are not known. This work examines the interaction between P and M during RSV assembly and budding. We show that M interacts with P in the absence of other viral proteins in cells using a Split Nano Luciferase assay. By using recombinant proteins, we demonstrate a direct interaction between M and P. By using Nuclear Magnetic Resonance (NMR) we identify three novel M interaction sites on P, namely site I in the αN2 region, site II in the 115-125 region, and the oligomerization domain (OD). We show that the OD, and likely the tetrameric structural organization of P, is required for virus-like filament formation and VLP release. Although sites I and II are not required for VLP formation, they appear to modulate P levels in RSV VLPs.Importance Human RSV is the commonest cause of infantile bronchiolitis in the developed world and of childhood deaths in resource-poor settings. It is a major unmet target for vaccines and anti-viral drugs. The lack of knowledge of RSV budding mechanism presents a continuing challenge for VLP production for vaccine purpose. We show that direct interaction between P and M modulates RSV VLP budding. This further emphasizes P as a central regulator of RSV life cycle, as an essential actor for transcription and replication early during infection and as a mediator for assembly and budding in the later stages for virus production.
Copyright © 2021 American Society for Microbiology.

Entities:  

Year:  2021        PMID: 33408180      PMCID: PMC8092690          DOI: 10.1128/JVI.02217-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  The nine C-terminal amino acids of the respiratory syncytial virus protein P are necessary and sufficient for binding to ribonucleoprotein complexes in which six ribonucleotides are contacted per N protein protomer.

Authors:  Thi-Lan Tran; Nathalie Castagné; David Bhella; Paloma F Varela; Julie Bernard; Stefan Chilmonczyk; Stefan Berkenkamp; Vanessa Benhamo; Katarina Grznarova; Jeanne Grosclaude; Claude Nespoulos; Felix A Rey; Jean-François Eléouët
Journal:  J Gen Virol       Date:  2007-01       Impact factor: 3.891

2.  Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers.

Authors:  Kurt A Swanson; Ethan C Settembre; Christine A Shaw; Antu K Dey; Rino Rappuoli; Christian W Mandl; Philip R Dormitzer; Andrea Carfi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-17       Impact factor: 11.205

3.  Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease.

Authors:  Yu-Na Lee; Hye Suk Hwang; Min-Chul Kim; Young-Tae Lee; Jong Seok Lee; Martin L Moore; Sang-Moo Kang
Journal:  Antiviral Res       Date:  2014-12-13       Impact factor: 5.970

4.  C-Terminal DxD-Containing Sequences within Paramyxovirus Nucleocapsid Proteins Determine Matrix Protein Compatibility and Can Direct Foreign Proteins into Budding Particles.

Authors:  Greeshma Ray; Phuong Tieu Schmitt; Anthony P Schmitt
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

5.  Taxonomy of the order Mononegavirales: update 2016.

Authors:  Claudio L Afonso; Gaya K Amarasinghe; Krisztián Bányai; Yīmíng Bào; Christopher F Basler; Sina Bavari; Nicolás Bejerman; Kim R Blasdell; François-Xavier Briand; Thomas Briese; Alexander Bukreyev; Charles H Calisher; Kartik Chandran; Jiāsēn Chéng; Anna N Clawson; Peter L Collins; Ralf G Dietzgen; Olga Dolnik; Leslie L Domier; Ralf Dürrwald; John M Dye; Andrew J Easton; Hideki Ebihara; Szilvia L Farkas; Juliana Freitas-Astúa; Pierre Formenty; Ron A M Fouchier; Yànpíng Fù; Elodie Ghedin; Michael M Goodin; Roger Hewson; Masayuki Horie; Timothy H Hyndman; Dàohóng Jiāng; Elliot W Kitajima; Gary P Kobinger; Hideki Kondo; Gael Kurath; Robert A Lamb; Sergio Lenardon; Eric M Leroy; Ci-Xiu Li; Xian-Dan Lin; Lìjiāng Liú; Ben Longdon; Szilvia Marton; Andrea Maisner; Elke Mühlberger; Sergey V Netesov; Norbert Nowotny; Jean L Patterson; Susan L Payne; Janusz T Paweska; Rick E Randall; Bertus K Rima; Paul Rota; Dennis Rubbenstroth; Martin Schwemmle; Mang Shi; Sophie J Smither; Mark D Stenglein; David M Stone; Ayato Takada; Calogero Terregino; Robert B Tesh; Jun-Hua Tian; Keizo Tomonaga; Noël Tordo; Jonathan S Towner; Nikos Vasilakis; Martin Verbeek; Viktor E Volchkov; Victoria Wahl-Jensen; John A Walsh; Peter J Walker; David Wang; Lin-Fa Wang; Thierry Wetzel; Anna E Whitfield; Ji Tāo Xiè; Kwok-Yung Yuen; Yong-Zhen Zhang; Jens H Kuhn
Journal:  Arch Virol       Date:  2016-05-23       Impact factor: 2.574

6.  Capturing enveloped viruses on affinity grids for downstream cryo-electron microscopy applications.

Authors:  Gabriella Kiss; Xuemin Chen; Melinda A Brindley; Patricia Campbell; Claudio L Afonso; Zunlong Ke; Jens M Holl; Ricardo C Guerrero-Ferreira; Lauren A Byrd-Leotis; John Steel; David A Steinhauer; Richard K Plemper; Deborah F Kelly; Paul W Spearman; Elizabeth R Wright
Journal:  Microsc Microanal       Date:  2013-11-26       Impact factor: 4.127

7.  Biochemical characterization of the respiratory syncytial virus P-P and P-N protein complexes and localization of the P protein oligomerization domain.

Authors:  Nathalie Castagné; Alexandra Barbier; Julie Bernard; Human Rezaei; Jean-Claude Huet; Céline Henry; Bruno Da Costa; Jean-François Eléouët
Journal:  J Gen Virol       Date:  2004-06       Impact factor: 3.891

8.  Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study.

Authors: 
Journal:  Lancet       Date:  2019-06-27       Impact factor: 202.731

9.  Structure of the human metapneumovirus polymerase phosphoprotein complex.

Authors:  Junhua Pan; Xinlei Qian; Simon Lattmann; Abbas El Sahili; Tiong Han Yeo; Huan Jia; Tessa Cressey; Barbara Ludeke; Sarah Noton; Marian Kalocsay; Rachel Fearns; Julien Lescar
Journal:  Nature       Date:  2019-11-07       Impact factor: 49.962

10.  RSV hijacks cellular protein phosphatase 1 to regulate M2-1 phosphorylation and viral transcription.

Authors:  Charles-Adrien Richard; Vincent Rincheval; Safa Lassoued; Jenna Fix; Christophe Cardone; Camille Esneau; Sergei Nekhai; Marie Galloux; Marie-Anne Rameix-Welti; Christina Sizun; Jean-François Eléouët
Journal:  PLoS Pathog       Date:  2018-02-28       Impact factor: 6.823

View more
  3 in total

1.  Tetramerization of Phosphoprotein is Essential for Respiratory Syncytial Virus Budding while its N Terminal Region Mediates Direct Interactions with the Matrix Protein.

Authors:  Monika Bajorek; Marie Galloux; Charles-Adrien Richard; Or Szekely; Rina Rosenzweig; Christina Sizun; Jean-Francois Eleouet
Journal:  J Virol       Date:  2021-01-06       Impact factor: 5.103

Review 2.  Interactions between the Nucleoprotein and the Phosphoprotein of Pneumoviruses: Structural Insight for Rational Design of Antivirals.

Authors:  Hortense Decool; Lorène Gonnin; Irina Gutsche; Christina Sizun; Jean-François Eléouët; Marie Galloux
Journal:  Viruses       Date:  2021-12-06       Impact factor: 5.048

3.  Respiratory syncytial virus ribonucleoproteins hijack microtubule Rab11 dependent transport for intracellular trafficking.

Authors:  Gina Cosentino; Katherine Marougka; Aurore Desquesnes; Nicolas Welti; Delphine Sitterlin; Elyanne Gault; Marie-Anne Rameix-Welti
Journal:  PLoS Pathog       Date:  2022-07-07       Impact factor: 7.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.